Impaired pituitary response to bromocriptine suppression: reversal after bromocriptine plus tamoxifen.
D000238:Adenoma, Chromophobe / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D001971:Bromocriptine / Q000009:adverse effects / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D010902:Pituitary Gland / Q000187:drug effects*; D010911:Pituitary Neoplasms / Q000188:drug therapy; D011388:Prolactin / Q000097:blood*; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use*
D013629:Tamoxifen; D001971:Bromocriptine; D011388:Prolactin